Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 247 entries
Sorted by: Best Match Show Resources per page
Production and effect of aldonic acids during enzymatic hydrolysis of lignocellulose at high dry matter content.

Biotechnology for biofuels

Cannella D, Hsieh CW, Felby C, Jørgensen H.
PMID: 22546481
Biotechnol Biofuels. 2012 Apr 30;5(1):26. doi: 10.1186/1754-6834-5-26.

BACKGROUND: The recent discovery of accessory proteins that boost cellulose hydrolysis has increased the economical and technical efficiency of processing cellulose to bioethanol. Oxidative enzymes (e.g. GH61) present in new commercial enzyme preparations have shown to increase cellulose conversion...

Cite
Cannella D, Hsieh CW, Felby C, et al. Production and effect of aldonic acids during enzymatic hydrolysis of lignocellulose at high dry matter content. Biotechnol Biofuels. 2012;5(1):26doi: 10.1186/1754-6834-5-26.
Cannella, D., Hsieh, C. W., Felby, C., & Jørgensen, H. (2012). Production and effect of aldonic acids during enzymatic hydrolysis of lignocellulose at high dry matter content. Biotechnology for biofuels, 5(1), 26. https://doi.org/10.1186/1754-6834-5-26
Cannella, David, et al. "Production and effect of aldonic acids during enzymatic hydrolysis of lignocellulose at high dry matter content." Biotechnology for biofuels vol. 5,1 (2012): 26. doi: https://doi.org/10.1186/1754-6834-5-26
Cannella D, Hsieh CW, Felby C, Jørgensen H. Production and effect of aldonic acids during enzymatic hydrolysis of lignocellulose at high dry matter content. Biotechnol Biofuels. 2012 Apr 30;5(1):26. doi: 10.1186/1754-6834-5-26. PMID: 22546481; PMCID: PMC3458932.
Copy Download .nbib Format: NLM
Improving cellulases hydrolytic action: An expanded role for electron donors of lytic polysaccharide monooxygenases in cellulose saccharification.

Bioresource technology

Xin D, Blossom BM, Lu X, Felby C.
PMID: 34999190
Bioresour Technol. 2022 Jan 06;346:126662. doi: 10.1016/j.biortech.2021.126662. Epub 2022 Jan 06.

Ascorbic acid (AscA) and gallic acid (GalA) are common electron donors and their boosting effect on lytic polysaccharide monooxygenases (LPMO) has been studied extensively. However, their influence on cellulase hydrolytic action has been ignored. In this work, the effect...

Cite
Xin D, Blossom BM, Lu X, et al. Improving cellulases hydrolytic action: An expanded role for electron donors of lytic polysaccharide monooxygenases in cellulose saccharification. Bioresour Technol. 2022;346:126662doi: 10.1016/j.biortech.2021.126662.
Xin, D., Blossom, B. M., Lu, X., & Felby, C. (2022). Improving cellulases hydrolytic action: An expanded role for electron donors of lytic polysaccharide monooxygenases in cellulose saccharification. Bioresource technology, 346126662. https://doi.org/10.1016/j.biortech.2021.126662
Xin, Donglin, et al. "Improving cellulases hydrolytic action: An expanded role for electron donors of lytic polysaccharide monooxygenases in cellulose saccharification." Bioresource technology vol. 346 (2022): 126662. doi: https://doi.org/10.1016/j.biortech.2021.126662
Xin D, Blossom BM, Lu X, Felby C. Improving cellulases hydrolytic action: An expanded role for electron donors of lytic polysaccharide monooxygenases in cellulose saccharification. Bioresour Technol. 2022 Jan 06;346:126662. doi: 10.1016/j.biortech.2021.126662. Epub 2022 Jan 06. PMID: 34999190.
Copy Download .nbib Format: NLM
Pyoverdine Assay for Rapid and Early Detection of .

ACS applied bio materials

Cueva AR, Pham O, Diaby A, Fleming D, Rumbaugh KP, Fernandes GE.
PMID: 35021709
ACS Appl Bio Mater. 2020 Aug 17;3(8):5350-5356. doi: 10.1021/acsabm.0c00665. Epub 2020 Jul 24.

Infection is responsible for up to 60% of deaths in burn patients, and

Cite
Cueva AR, Pham O, Diaby A, et al. Pyoverdine Assay for Rapid and Early Detection of . ACS Appl Bio Mater. 2020;3(8):5350-5356doi: 10.1021/acsabm.0c00665.
Cueva, A. R., Pham, O., Diaby, A., Fleming, D., Rumbaugh, K. P., & Fernandes, G. E. (2020). Pyoverdine Assay for Rapid and Early Detection of . ACS applied bio materials, 3(8), 5350-5356. https://doi.org/10.1021/acsabm.0c00665
Cueva, Angel R, et al. "Pyoverdine Assay for Rapid and Early Detection of ." ACS applied bio materials vol. 3,8 (2020): 5350-5356. doi: https://doi.org/10.1021/acsabm.0c00665
Cueva AR, Pham O, Diaby A, Fleming D, Rumbaugh KP, Fernandes GE. Pyoverdine Assay for Rapid and Early Detection of . ACS Appl Bio Mater. 2020 Aug 17;3(8):5350-5356. doi: 10.1021/acsabm.0c00665. Epub 2020 Jul 24. PMID: 35021709.
Copy Download .nbib Format: NLM
CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells.

FEBS open bio

Li S, Garay JP, Tubbs CA, Franco HL.
PMID: 33666335
FEBS Open Bio. 2021 Jun;11(6):1537-1551. doi: 10.1002/2211-5463.13139. Epub 2021 Mar 20.

Precise genome engineering of living cells has been revolutionized by the introduction of the highly specific and easily programmable properties of the clustered regularly interspaced short palindromic repeats (CRISPR) technology. This has greatly accelerated research into human health and...

Cite
Li S, Garay JP, Tubbs CA, et al. CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells. FEBS Open Bio. 2021;11(6):1537-1551doi: 10.1002/2211-5463.13139.
Li, S., Garay, J. P., Tubbs, C. A., & Franco, H. L. (2021). CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells. FEBS open bio, 11(6), 1537-1551. https://doi.org/10.1002/2211-5463.13139
Li, Shen, et al. "CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells." FEBS open bio vol. 11,6 (2021): 1537-1551. doi: https://doi.org/10.1002/2211-5463.13139
Li S, Garay JP, Tubbs CA, Franco HL. CRISPR-based knock-in mutagenesis of the pioneer transcription factor FOXA1: optimization of strategies for multi-allelic proteins in cancer cells. FEBS Open Bio. 2021 Jun;11(6):1537-1551. doi: 10.1002/2211-5463.13139. Epub 2021 Mar 20. PMID: 33666335; PMCID: PMC8167868.
Copy Download .nbib Format: NLM
Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19.

The Lancet. Respiratory medicine

Milross L, Majo J, Cooper N, Kaye PM, Bayraktar O, Filby A, Fisher AJ.
PMID: 34871544
Lancet Respir Med. 2022 Jan;10(1):95-106. doi: 10.1016/S2213-2600(21)00408-2. Epub 2021 Dec 03.

The lungs are the main site that is affected in severe COVID-19, and post-mortem lung tissue provides crucial insights into the pathophysiology of severe disease. From basic histology to state-of-the-art multiparameter digital pathology technologies, post-mortem lung tissue provides snapshots...

Cite
Milross L, Majo J, Cooper N, et al. Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19. Lancet Respir Med. 2021;10(1):95-106doi: 10.1016/S2213-2600(21)00408-2.
Milross, L., Majo, J., Cooper, N., Kaye, P. M., Bayraktar, O., Filby, A., & Fisher, A. J. (2022). Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19. The Lancet. Respiratory medicine, 10(1), 95-106. https://doi.org/10.1016/S2213-2600(21)00408-2
Milross, Luke, et al. "Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19." The Lancet. Respiratory medicine vol. 10,1 (2022): 95-106. doi: https://doi.org/10.1016/S2213-2600(21)00408-2
Milross L, Majo J, Cooper N, Kaye PM, Bayraktar O, Filby A, Fisher AJ. Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19. Lancet Respir Med. 2022 Jan;10(1):95-106. doi: 10.1016/S2213-2600(21)00408-2. Epub 2021 Dec 03. PMID: 34871544; PMCID: PMC8641959.
Copy Download .nbib Format: NLM
An interview with A. Koneti Rao: Editor of Platelets (1990-2018).

Platelets

Halford GM, Dalby A.
PMID: 33775214
Platelets. 2021 Aug 18;32(6):717-721. doi: 10.1080/09537104.2021.1904329. Epub 2021 Mar 27.

Professor A. Koneti Rao has made many critical contributions to the field of platelet research for over forty years. He joined the editorial board of

Cite
Halford GM, Dalby A. An interview with A. Koneti Rao: Editor of Platelets (1990-2018). Platelets. 2021;32(6):717-721doi: 10.1080/09537104.2021.1904329.
Halford, G. M., & Dalby, A. (2021). An interview with A. Koneti Rao: Editor of Platelets (1990-2018). Platelets, 32(6), 717-721. https://doi.org/10.1080/09537104.2021.1904329
Halford, Gayle M, and Dalby, Amanda. "An interview with A. Koneti Rao: Editor of Platelets (1990-2018)." Platelets vol. 32,6 (2021): 717-721. doi: https://doi.org/10.1080/09537104.2021.1904329
Halford GM, Dalby A. An interview with A. Koneti Rao: Editor of Platelets (1990-2018). Platelets. 2021 Aug 18;32(6):717-721. doi: 10.1080/09537104.2021.1904329. Epub 2021 Mar 27. PMID: 33775214.
Copy Download .nbib Format: NLM
A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations.

Journal of substance abuse treatment

Kidd JD, Paschen-Wolff MM, Mericle AA, Caceres BA, Drabble LA, Hughes TL.
PMID: 34175174
J Subst Abuse Treat. 2022 Feb;133:108539. doi: 10.1016/j.jsat.2021.108539. Epub 2021 Jun 16.

BACKGROUND: Alcohol, tobacco, and other drug use are among the most prevalent and important health disparities affecting sexual and gender minority (SGM; e.g., lesbian, gay, bisexual, transgender) populations. Although numerous government agencies and health experts have called for substance...

Cite
Kidd JD, Paschen-Wolff MM, Mericle AA, et al. A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations. J Subst Abuse Treat. 2021;133:108539doi: 10.1016/j.jsat.2021.108539.
Kidd, J. D., Paschen-Wolff, M. M., Mericle, A. A., Caceres, B. A., Drabble, L. A., & Hughes, T. L. (2022). A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations. Journal of substance abuse treatment, 133108539. https://doi.org/10.1016/j.jsat.2021.108539
Kidd, Jeremy D, et al. "A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations." Journal of substance abuse treatment vol. 133 (2022): 108539. doi: https://doi.org/10.1016/j.jsat.2021.108539
Kidd JD, Paschen-Wolff MM, Mericle AA, Caceres BA, Drabble LA, Hughes TL. A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations. J Subst Abuse Treat. 2022 Feb;133:108539. doi: 10.1016/j.jsat.2021.108539. Epub 2021 Jun 16. PMID: 34175174; PMCID: PMC8674383.
Copy Download .nbib Format: NLM
Continuous endobronchial suctioning for refractory post lobectomy lung atelectasis: a case report.

Annals of translational medicine

Kouritas V, Ross N, Bilyy A, Hogan J, Parvez M, Kadlec J, Bartosik W, Van Tornout F.
PMID: 34268428
Ann Transl Med. 2021 May;9(9):815. doi: 10.21037/atm-20-3839.

The presentation of post lung resection atelectasis can vary between simple atelectasis and total lung collapse i.e., "white - out", making its treatment demanding in many occasions. We herein present the technique of continuous suctioning of the right upper...

Cite
Kouritas V, Ross N, Bilyy A, et al. Continuous endobronchial suctioning for refractory post lobectomy lung atelectasis: a case report. Ann Transl Med. 2021;9(9):815doi: 10.21037/atm-20-3839.
Kouritas, V., Ross, N., Bilyy, A., Hogan, J., Parvez, M., Kadlec, J., Bartosik, W., & Van Tornout, F. (2021). Continuous endobronchial suctioning for refractory post lobectomy lung atelectasis: a case report. Annals of translational medicine, 9(9), 815. https://doi.org/10.21037/atm-20-3839
Kouritas, Vasileios, et al. "Continuous endobronchial suctioning for refractory post lobectomy lung atelectasis: a case report." Annals of translational medicine vol. 9,9 (2021): 815. doi: https://doi.org/10.21037/atm-20-3839
Kouritas V, Ross N, Bilyy A, Hogan J, Parvez M, Kadlec J, Bartosik W, Van Tornout F. Continuous endobronchial suctioning for refractory post lobectomy lung atelectasis: a case report. Ann Transl Med. 2021 May;9(9):815. doi: 10.21037/atm-20-3839. PMID: 34268428; PMCID: PMC8246213.
Copy Download .nbib Format: NLM
Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society

Chen C, Mossman E, Malko P, McDonald D, Blain AP, Bone L, Erskine D, Filby A, Vincent AE, Hudson G, Reeve AK.
PMID: 34779538
Mov Disord. 2021 Nov 15; doi: 10.1002/mds.28849. Epub 2021 Nov 15.

BACKGROUND: Mitochondrial dysfunction within neurons, particularly those of the substantia nigra, has been well characterized in Parkinson's disease and is considered to be related to the pathogenesis of this disorder. Dysfunction within this important organelle has been suggested to...

Cite
Chen C, Mossman E, Malko P, et al. Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease. Mov Disord. 2021;doi: 10.1002/mds.28849.
Chen, C., Mossman, E., Malko, P., McDonald, D., Blain, A. P., Bone, L., Erskine, D., Filby, A., Vincent, A. E., Hudson, G., & Reeve, A. K. (2021). Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, . https://doi.org/10.1002/mds.28849
Chen, Chun, et al. "Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease." Movement disorders : official journal of the Movement Disorder Society vol. (2021). doi: https://doi.org/10.1002/mds.28849
Chen C, Mossman E, Malko P, McDonald D, Blain AP, Bone L, Erskine D, Filby A, Vincent AE, Hudson G, Reeve AK. Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease. Mov Disord. 2021 Nov 15; doi: 10.1002/mds.28849. Epub 2021 Nov 15. PMID: 34779538.
Copy Download .nbib Format: NLM
The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.

Chest

Asciak R, Kanellakis NI, Bibby A, Kidd A, Gerry S, Mercer R, Maskell N, Blyth KG, Fsadni P, Montefort S, Psallidas I, Rahman NM.
PMID: 34119515
Chest. 2021 Nov;160(5):1925-1933. doi: 10.1016/j.chest.2021.05.063. Epub 2021 Jun 11.

BACKGROUND: Most patients with malignant pleural mesothelioma (MPM) seek treatment with malignant pleural effusion (MPE). In vitro evidence suggests that MPE may not be a simple bystander of malignancy, but rather potentially has biological properties that improve cancer cell...

Cite
Asciak R, Kanellakis NI, Bibby A, et al. The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma. Chest. 2021;160(5):1925-1933doi: 10.1016/j.chest.2021.05.063.
Asciak, R., Kanellakis, N. I., Bibby, A., Kidd, A., Gerry, S., Mercer, R., Maskell, N., Blyth, K. G., Fsadni, P., Montefort, S., Psallidas, I., & Rahman, N. M. (2021). The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma. Chest, 160(5), 1925-1933. https://doi.org/10.1016/j.chest.2021.05.063
Asciak, Rachelle, et al. "The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma." Chest vol. 160,5 (2021): 1925-1933. doi: https://doi.org/10.1016/j.chest.2021.05.063
Asciak R, Kanellakis NI, Bibby A, Kidd A, Gerry S, Mercer R, Maskell N, Blyth KG, Fsadni P, Montefort S, Psallidas I, Rahman NM. The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma. Chest. 2021 Nov;160(5):1925-1933. doi: 10.1016/j.chest.2021.05.063. Epub 2021 Jun 11. PMID: 34119515.
Copy Download .nbib Format: NLM
Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential.

Antibody therapeutics

Mullen TE, Abdullah R, Boucher J, Brousseau AS, Dasuri NK, Ditto NT, Doucette AM, Emery C, Gabriel J, Greamo B, Patil KS, Rothenberger K, Stolte J, Souders CA.
PMID: 34541454
Antib Ther. 2021 Aug 28;4(3):185-196. doi: 10.1093/abt/tbab018. eCollection 2021 Jul.

BACKGROUND: Rapid deployment of technologies capable of high-throughput and high-resolution screening is imperative for timely response to viral outbreaks. Risk mitigation in the form of leveraging multiple advanced technologies further increases the likelihood of identifying efficacious treatments in aggressive...

Cite
Mullen TE, Abdullah R, Boucher J, et al. Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential. Antib Ther. 2021;4(3):185-196doi: 10.1093/abt/tbab018.
Mullen, T. E., Abdullah, R., Boucher, J., Brousseau, A. S., Dasuri, N. K., Ditto, N. T., Doucette, A. M., Emery, C., Gabriel, J., Greamo, B., Patil, K. S., Rothenberger, K., Stolte, J., & Souders, C. A. (2021). Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential. Antibody therapeutics, 4(3), 185-196. https://doi.org/10.1093/abt/tbab018
Mullen, Tracey E, et al. "Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential." Antibody therapeutics vol. 4,3 (2021): 185-196. doi: https://doi.org/10.1093/abt/tbab018
Mullen TE, Abdullah R, Boucher J, Brousseau AS, Dasuri NK, Ditto NT, Doucette AM, Emery C, Gabriel J, Greamo B, Patil KS, Rothenberger K, Stolte J, Souders CA. Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential. Antib Ther. 2021 Aug 28;4(3):185-196. doi: 10.1093/abt/tbab018. eCollection 2021 Jul. PMID: 34541454; PMCID: PMC8444149.
Copy Download .nbib Format: NLM
Comparative Effectiveness of Behavioral Interventions for Cardiovascular Risk Reduction in Latinos: A Systematic Review.

The Journal of cardiovascular nursing

Estrada LV, Solano J, Reading Turchioe M, Cortes YI, Caceres BA.
PMID: 33938534
J Cardiovasc Nurs. 2021 Apr 30; doi: 10.1097/JCN.0000000000000806. Epub 2021 Apr 30.

BACKGROUND: Latinos, the fastest growing ethnic minority group in the United States, are at a high risk for cardiovascular disease (CVD). However, little is known about effective strategies to reduce CVD risk in this population.OBJECTIVE: The aim of this...

Cite
Estrada LV, Solano J, Reading Turchioe M, et al. Comparative Effectiveness of Behavioral Interventions for Cardiovascular Risk Reduction in Latinos: A Systematic Review. J Cardiovasc Nurs. 2021;doi: 10.1097/JCN.0000000000000806.
Estrada, L. V., Solano, J., Reading Turchioe, M., Cortes, Y. I., & Caceres, B. A. (2021). Comparative Effectiveness of Behavioral Interventions for Cardiovascular Risk Reduction in Latinos: A Systematic Review. The Journal of cardiovascular nursing, . https://doi.org/10.1097/JCN.0000000000000806
Estrada, Leah V, et al. "Comparative Effectiveness of Behavioral Interventions for Cardiovascular Risk Reduction in Latinos: A Systematic Review." The Journal of cardiovascular nursing vol. (2021). doi: https://doi.org/10.1097/JCN.0000000000000806
Estrada LV, Solano J, Reading Turchioe M, Cortes YI, Caceres BA. Comparative Effectiveness of Behavioral Interventions for Cardiovascular Risk Reduction in Latinos: A Systematic Review. J Cardiovasc Nurs. 2021 Apr 30; doi: 10.1097/JCN.0000000000000806. Epub 2021 Apr 30. PMID: 33938534; PMCID: PMC8556412.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 247 entries